Six-month oral clarithromycin regimen is safe and active in extranodal marginal zone B-cell lymphomas: final results of a single-centre phase II trial

Authors :: Giada Licata
Maurilio Ponzoni
Roberto Crocchiolo
G.P. Dognini
Silvia Govi
Andrés J.M. Ferreri
Antonio Giordano Resti
Govi, S
Dognini, Gp
Licata, G
Crocchiolo, R
Resti, Ag
Ponzoni, Maurilio
Ferreri, Ajm
Source :: British Journal of Haematology.
Publication Year :: 2010
Publisher :: Wiley, 2010.

Subjects :: medicine.medical_specialty
Protein synthesis inhibitor
business.industry
Hematology
medicine.disease
Lymphoma
Surgery
Clinical trial
Single centre
Regimen
medicine.anatomical_structure
Clarithromycin
Marginal zone B-cell
medicine
business
Lymph node
medicine.drug

Tools